1-6 of 6
Stephen A. Beers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance

Open Access
Massimiliano Mellone, Klaudia Piotrowska, Giulia Venturi, Lija James, Aleksandra Bzura, Maria A. Lopez, Sonya James, Chuan Wang, Matthew J. Ellis, Christopher J. Hanley, Josephine F. Buckingham, Kerry L. Cox, Gareth Hughes, Viia Valge-Archer, Emma V. King, Stephen A. Beers, Vincent Jaquet, George D.D. Jones, Natalia Savelyeva, Emre Sayan, Jason L. Parsons, Stephen Durant, Gareth J. Thomas
Journal: Cancer Research
Cancer Res (2022) 82 (24): 4571–4585.
https://doi.org/10.1158/0008-5472.CAN-22-0435
Published: 16 December 2022
View articletitled, ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance
Open the PDF for ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance in another window
Includes: Supplementary data
Journal Articles

Abstract 4156: BI-1808 - a first in class ligand-blocking αTNFR2 antibody for cancer immunotherapy

Free
Linda Mårtensson, Kirsty Cleary, Petra Holmkvist, Mathilda Kovacek, Carolin Svensson, Monika Semmrich, Therese Blidberg, Mimoza Demiri, Osman Dadas, Marie Borggren, Vici Pitic, Sean H. Lim, Stephen A. Beers, Susanne Gertsson, Kristoffer S. Rohrberg, Ingrid Karlsson, Andres McAllister, Mark S. Cragg, Björn Frendeus, Ingrid Teige
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 4156.
https://doi.org/10.1158/1538-7445.AM2022-4156
Published: 15 June 2022
View articletitled, Abstract 4156: BI-1808 - a first in class ligand-blocking αTNFR2 antibody for cancer immunotherapy
Journal Articles

Abstract 1642: A novel FcγRIIB-blocking antibody to enhance FcγR-dependent antitumor immunity

Free
Linda Mårtensson, Robert Oldham, Marie Borggren, Mathilda Kovacek, Therese Blidberg, Ali Roghanian, Ulla-Carin Thornberg, Ingrid Karlsson, Stephen A. Beers, Mark S. Cragg, Ingrid Teige, Bjorn L. Frendéus
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1642.
https://doi.org/10.1158/1538-7445.AM2021-1642
Published: 01 July 2021
View articletitled, Abstract 1642: A novel FcγRIIB-blocking antibody to enhance FcγR-dependent antitumor immunity
Journal Articles

Abstract 936: Targeting TNFR2 for cancer immunotherapy: Ligand blocking depletors versus receptor agonists

Free
Linda Mårtensson, Kirstie Cleary, Monika Semmrich, Mathilda Kovacek, Petra Holmkvist, Caroline Svensson, Mimoza Demiri, Therese Blidberg, Ulla-Carin Thornberg, Vincentiu Pitic, Osman Dadas, Sean H. Lim, Stephen A. Beers, Mark S. Cragg, Björn Frendéus, Ingrid Teige
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 936.
https://doi.org/10.1158/1538-7445.AM2020-936
Published: 15 August 2020
View articletitled, Abstract 936: Targeting TNFR2 for cancer immunotherapy: Ligand blocking depletors versus receptor agonists
Journal Articles

STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy

Available to Purchase
Lekh N. Dahal, Lang Dou, Khiyam Hussain, Rena Liu, Alexander Earley, Kerry L. Cox, Salome Murinello, Ian Tracy, Francesco Forconi, Andrew J. Steele, Patrick J. Duriez, Diego Gomez-Nicola, Jessica L. Teeling, Martin J. Glennie, Mark S. Cragg, Stephen A. Beers
Journal: Cancer Research
Cancer Res (2017) 77 (13): 3619–3631.
https://doi.org/10.1158/0008-5472.CAN-16-2784
Published: 02 July 2017
View articletitled, STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy
Open the PDF for STING Activation Reverses Lymphoma-Mediated Resistance to Antibody Immunotherapy in another window
Includes: Supplementary data
Journal Articles

TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb—Letter

Available to Purchase
Anna H. Turaj, Lekh N. Dahal, Stephen A. Beers, Mark S. Cragg, Sean H. Lim
Journal: Cancer Research
Cancer Res (2017) 77 (12): 3376–3378.
https://doi.org/10.1158/0008-5472.CAN-17-0412
Published: 14 June 2017
View articletitled, TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb—Letter
Open the PDF for TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb—Letter in another window